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http://www.biomedcentral.com/1752-0509/7/41RESEARCH ARTICLE Open AccessComputational modelling of the regulation of
Insulin signalling by oxidative stress
Graham R Smith and Daryl P Shanley*Abstract
Background: Existing models of insulin signalling focus on short term dynamics, rather than the longer term
dynamics necessary to understand many physiologically relevant behaviours. We have developed a model of insulin
signalling in rodent adipocytes that includes both transcriptional feedback through the Forkhead box type O
(FOXO) transcription factor, and interaction with oxidative stress, in addition to the core pathway. In the model
Reactive Oxygen Species are both generated endogenously and can be applied externally. They regulate signalling
though inhibition of phosphatases and induction of the activity of Stress Activated Protein Kinases, which
themselves modulate feedbacks to insulin signalling and FOXO.
Results: Insulin and oxidative stress combined produce a lower degree of activation of insulin signalling than
insulin alone. Fasting (nutrient withdrawal) and weak oxidative stress upregulate antioxidant defences while
stronger oxidative stress leads to a short term activation of insulin signalling but if prolonged can have other effects
including degradation of the insulin receptor substrate (IRS1) and FOXO. At high insulin the protective effect of
moderate oxidative stress may disappear.
Conclusion: Our model is consistent with a wide range of experimental data, some of which is difficult to explain.
Oxidative stress can have effects that are both up- and down-regulatory on insulin signalling. Our model therefore
shows the complexity of the interaction between the two pathways and highlights the need for such integrated
computational models to give insight into the dysregulation of insulin signalling along with more data at the
individual level.
A complete SBML model file can be downloaded from BIOMODELS (https://www.ebi.ac.uk/biomodels-main) with
unique identifier MODEL1212210000.
Other files and scripts are available as additional files with this journal article and can be downloaded from https://
github.com/graham1034/Smith2012_insulin_signalling.
Keywords: Insulin signalling, FOXO, Oxidative stress, Kinetic computational modellingBackground
Nutrient response signalling pathways are activated in
response to feeding and control such aspects of an
organism’s response to feeding as satiety and the gene-
ration, consumption and storage of energy. They also
control the allocation of energy and biological substrates
to somatic growth, maintenance and repair, and so
implicitly underlie theories of ageing such as the Disposable
Soma Theory [1] which are based on the idea of trade-offs
between these processes. In the animal kingdom the* Correspondence: daryl.shanley@newcastle.ac.uk
Centre for Integrated Systems Biology of Ageing & Nutrition (CISBAN),
Institute for Ageing and Health, Newcastle University, Campus for Ageing
and Vitality, Newcastle upon Tyne NE4 5PL, UK
© 2013 Smith and Shanley; licensee BioMed C
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediuminsulin-signalling (IS) pathway is of particular importance
[2]. Dietary sugars trigger the production of insulin or
insulin-like peptides which are sensed by Insulin receptors
at the cell surface and initiate a kinase cascade, leading to
the activation of the downstream kinase Akt (PKB), the
translocation of GLUT4 glucose transporters to the cell
surface, and ultimately glucose uptake. Longer-term adap-
tive effects are controlled through transcription factors
such as FOXO, which is deactivated (via cytoplasmic
translocation) by Akt-mediated phosphorylation when IS
is active [3]. When active, FOXO transcribes genes regu-
lating cell cycle arrest, apoptosis, metabolism and main-
tenance [4,5]. Animal lifespan may be increased by
nutrient restriction in many animals including nematodes,entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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activity of IS [2,7,8]. In addition to its role in ageing,
dysregulation of IS is central in metabolic diseases such as
Type II Diabetes (T2D).
Oxidative stress is an inescapable concomitant of the
life of aerobic organisms, given that reactive oxygen
species (ROS) are produced by energy generation by
oxidative phosphorylation in mitochondria. ROS can
damage all main categories of biomolecule including
DNA, protein and lipids. Accordingly, organisms protect
themselves by the production of many classes of antioxi-
dant enzymes, including superoxide dismutase and
catalase (that catalyse reactions that lead ultimately to
the conversion of ROS to water), and thioredoxins and
peroxiredoxins (that use reversible oxidation of sulphy-
dryl groups to remove ROS) [9]. The extent of cellular
resistance to oxidative stress varies between organisms
and closely correlates with lifespan [10], and in the free
radical theory of ageing [11] the damage caused by ROS
is hypothesised to be the primary cause of age-related
degeneration [12]. Notwithstanding this, recent studies
have tended to emphasise that the levels of antioxidant
enzymes do not correlate with lifespan [13], and the
effects of overexpression or knockout of antioxidants, or
of dietary supplementation, are not always as might be
expected [14,15]. In addition ROS activate several stress-
activated protein kinases (SAPKs) such as JNK, IKK [16]
and p38 MAPK [17]. The response of IS to oxidative
stress is complicated by the fact that ROS has been co-
opted into the active regulation of the pathway, ROS
produced by NOX enzymes affecting IS immediately
through the reversible oxidation and inhibition of the
catalytic cysteine residues of the protein tyrosine phos-
phatases and lipid phosphatases that deactivate IS
[18-21]. The effect of ROS on IS has also been strongly
implicated in the development of metabolic disease such
as T2D [22-24] and neurodegenerative disease [25].
Given the complicated nature of these two important
processes and their interaction, especially the multiple
countervailing effects of ROS, a quantitative model is
essential to understand the biological consequences. In
particular, the ability of a computational model to quan-
tify multiple effects and study the effects of variation of
experimentally-inaccessible parameters may be expected
to lead to some insight. Motivated by this, we here
present a kinetic computational model of IS in rodent
adipocytes including FOXO and some FOXO-mediated
outputs, and including interactions with ROS and some
oxidative stress activated kinases. Previous modelling
work on IS has focused on receptor binding, the activa-
tion of Akt and Glucose uptake [26,27]. In recent years
it has expanded to include a more detailed description
of Insulin-InR binding [28], integration with connected
signalling pathways such as mTOR [29,30], EGF [31],MAPK [32] and whole-body insulin/glucose dynamics
[33], though these aspects are not included in the model
presented here. We have used work by Sedaghat et al.
[26] as the basis of our modelling of IS and integrated it
with a model we previously developed of the regulation
of the FOXO transcription factor by multiple post-
translational modifications (PTMS) [34]. The role of
stress-activated kinases JNK and IKK in regulating
FOXO was already included in this model; here we have
extended this to include their regulation of IS through
phosphorylation of IRS. ROS is included in the model
and leads to activation of SAPKs while also having a
direct effect on IS through the phosphatase-dependent
mechanism described above. In the model, insulin sti-
mulation leads to signalling-induced ROS through NOX
but not additional mitochondrially generated ROS resul-
ting from glucose uptake (this would be an oversim-
plification in other tissues such as muscle, where
mitochondrially generated ROS makes up a larger frac-
tion of the total). Aspects of a recent model of the anti-
oxidant system [35] describing the transport of oxidants
between the extracellular and cytoplasmic compartment
were included; this enables connection with experiments
in which oxidants (hydrogen peroxide) are externally
applied. We develop a model integrating multiple ex-
perimental findings on the IS and oxidative stress sys-
tems and study its behaviour in scenarios of nutrient
withdrawal, the simultaneous applications of Insulin and
ROS, and the effects of low and high oxidative stress on
insulin response.
Results
The modules making up the model are shown diagram-
matically in Figure 1, with outputs shown in Figure 2.
Molecule numbers are given in Table 1 and kinetic
parameters in Tables 2, 3 and 4. Differential equations
are given in Additional file 1. Mass action kinetics are
used for the majority of equations, except activation of
Akt and PKC and JNK/IKK mediated feedbacks on IRS.
The modules in Figure 1A-C make up the core insulin
signalling pathway and Figure 2A-C show its behaviour
in response to insulin. ROS production and SAPK
activation modules are described in Figure 1D-E and
their behaviour is shown in Figure 2D-G. The FOXO
module is shown in Figure 1F and its behaviour in
Figure 2H.
Model development and parameter estimation
Insulin signalling
The parameters in the insulin signalling pathway itself
were arrived at as follows. Model development was started
with the model in Sedaghat et al. [26] as a basis, but was
substantially refitted in the light of the timecourse of
PTP1B inhibition and extra data. Various sources were
A B
C D
E F
Figure 1 Block diagrams of the model. (A): Insulin – Insulin Receptor binding and InR activation; (B): IRS regulation by active InR, PKC, JNK and
IKK and IRS – PI3K binding; (C) downstream activation of Akt though the IRS– PI3K complex and PIP3, and GLUT4 transport to the plasma
membrane; (D) ROS production basally (by Mt) and insulin-stimulated (by NOX); ROS transport across the plasma membrane; ROS degradation by
SOD2; inhibition of PTP and PTEN by ROS and reactivation by GSH; (E) activation of JNK and IKK by ROS; (F) FOXO regulation by Akt, JNK and IKK;
FOXO synthesis and degradation; FOXO transport between compartments; transcriptional regulation of InR and SOD2 by FOXO. The presence of
the PTMs applied to FOXO by the kinases affects the transport and degradation rates, as detailed in Table 3.
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[38,39]. In the receptor binding module, insulin binding
and unbinding (k1 and kminus1) were fitted using data on
bound insulin in rat adipocytes from Stagsted et al.
Figure 1 [36]. In the IRS module k7 and kminus7 were
fitted to IRS_tyrosine phosphorylation data in human adi-
pocytes from Cedersund et al. [27] to get the rapid rise. k8
and k-8, the rate constants for Reaction 13, the formation
of the IRS-PI3K complex, were fitted to PI3K activation
kinetics from Stagsted et al. Figure 3 [36], with the
additional information that max PI3K = 0.05 of total [26].
Parameters of PIP3 production and degradation were
fitted to give PIP3 activation on a timescale of 30s, risingfrom 0.003 (basal) to 0.03 (maximum stimulated) [26].
Parameters of Akt and PKC activation (reactions R16
and R17) were chosen to give maximum insulin-
stimulated Akt and PKC phosphorylation = 10% of total
after 2 minutes. The exact time is uncertain given the data
used here but must be rapid to enable parameters of
IRS – serine phosphorylation (in R12af) to produce the
observed feedback inhibition of IRS1. In the rate law, an
offset to the mass-action dependence on PIP3 was used to
give zero Akt/PKC activation below the basal PIP3 level
(parameter pip3_basal; see Additional file 1). Glucose up-
take is proxied by cell surface GLUT4, and so GLUT4
parameters were chosen so that a fraction 0.1 of GLUT4 is
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Figure 2 (See legend on next page.)
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Figure 2 Short-term effects of insulin signalling and Oxidative stress. (A) Insulin (100 nM; dosing bar) activates Akt leading to Glut4
translocation and Glucose uptake (timecourses). Akt timecourse reproduces Sedaghat et al. [26]; (B) Dose response curves for bound insulin, PI3K
activation and Glucose uptake; data adapted from experiments by Stagstad et al. [36] in rat adipocytes; (C) Insulin activates IRS through Tyrosine
phosphorylation (IRS_Yp) and PKC inhibits through serine phosphorylation. (data adapted from experiments by Cedersund et al. [27] in human
adipocytes); (D) Endogenous ROS inhibits PTP1B (data adapted from experiments by Mahadev et al. [18] in mouse 3T3-L1 adiopocytes); (E)
Inhibition of NOX prevents oxidation-mediated inactivation of PTP1B and moves D-R curves of IS components to higher insulin concentrations;
(F) Antioxidants control internal ROS until external ROS passes a threshold (calculations based on a model developed by Adimora et al. [35] in
human Jurkat T cells); (G) ROS activates JNK/IKK; (H) Insulin (through Akt) and ROS (through JNK) modulate FOXO subcellular localization.
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The fact that GLUT4 is not entirely surface located at its
maximum, but this maximum must occur at a lower
Insulin concentration than the peak activation of PI3K
(and Akt) activation, necessitates the addition of AS160
[55-57] between Akt and GLUT4 (otherwise, the further
activation of PI3K produces more GLUT4 translocation).Table 1 Particle numbers in initial conditions
Module Species Initial va
(number
Receptor binding Ins 5 × 105, b
InR 9 × 104
Cytoplasm_InR 1 × 104
PTP1B 1 × 105
IRS IRS1 1 × 105
PI3K 1 × 104
PP2A 5 × 105
Phosphatases PTEN 1 × 105
GSH 100
NOX_inact 100
Cytoplasm_SOD2 4.17 × 10
Mt 50
extracellular_ROS 5 × 104, b
Akt Akt 1 × 105
AS160 2 × 104
PKC 1 × 105
PIP2 2 × 105
PIP3 1 × 103
cytoplasm_GLUT4 9.6 × 104
cellsurface_GLUT4 4 × 103
JNK JNK 16000
IKK 2000
DUSP 1 × 105
FOXO E2F1 300
cytoplasm_Foxo1_Pa0 Pd0_Pe0_pUb0
(Foxo with no PTMs)
1000
All other species are initially zero.
Initial particle numbers in the model (all other species are initially zero).AS160 is fully activated by partial activation of Akt, at an
Insulin concentration of around 1 nM, but even when fully
activated leads to only a partial translocation of GLUT4.
ROS production and signalling
Insulin stimulation is associated with the production of
ROS (hydrogen peroxide) intracellularly [18] and it haslue
of molecules)
Comments & References
oundary 10-7 M
BioNumbers [37]
<< cell surface
assigned (PaxDb suggests PTPN1 5 × 105 in human,
5 × 104 in mouse) http://pax-db.org & [38,39]
[26] Appdx B
[26] Appdx B
[40]
PaxDb, human
assigned
assigned
4 scale 10-3 * PaxDb
assigned
oundary scale 10-3 * 10 μM
[41]
assigned
assigned same as Akt
scale 10-3 *[26]; [42]
scale 10-3 * [26]; [42]
Total 1 × 105, assigned ((PaxDb suggests Slc2a4
5 × 104 in mouse)
PaxDB (Mapk9)
PaxDb (Ikbkb)
assigned
assigned, to keep FOXO ~ 1000
see [34]
Table 2 Parameter values of the model (except for FOXO part)
Module Reaction Name Parameter Value Order Comments & Ref
All Volume extracellular 8.3 × 10-12 l 0.5 × cytoplasm
Volume cell surface 6.4 × 10-14 l assumes thickness of 20 nm
Volume cytoplasm 1.65 × 10-11 l typical of many cells
Volume nucleus 5 × 10-13 l
Volume DNA-bound 1 × 10-13 l
Receptor binding R1f k1 2.0 × 10-5 2 [36] Figure 1
m8b2_recep.6mod R1r kminus1 12072 1 [36]
R2 k3 2500 1 [36]
R3f k2 1.2 × 10-5 2 [36]
R3r kminus2 9 × 104 1 > > kminus1
R4 kminus3 2 × 10-6 2 (cat)
R5f k4 0.0333 1 forward/reverse ratio 10, much
faster than [26]
R5r kminus4 0.3 1 see R5f
R6f k4’ 0.0021 1 unchanged from [26]
R6r kminus4’ 2.1 × 10-4 1 [26]
R7f k4’ 0.0021 1 [26]
R7r kminus4’ 2.1 × 10-4 1 [26]
R10 k6 4.61 × 10-6 2 (cat) [26] corrected for mol number
of PTP1B
R11 k6 4.61 × 10-6 2 (cat) see R10
IRS R12f k7 5.8 2 (cat) fitted to IRSYp
m8b2_irs.6.mod R12r kminus7a 8.75 × 10-5 2 (cat) as R12f
R12_a_f IRS-SerP by PKC_P kpsp2 2.2 × 10-4 2 changed to simple MA; [27]
used for fitting
R12_a_r kminus7b 0.28 × 10-5 2 (cat) as R12_a_f
R12_b_(f,r) as R12_a_(f,r)
R13f k8 2.6 × 10-6 2 [36] Figure 3
R13r kminus8 1.55 1 as R13f
R50f IRS basal synth k_irs1_basal_syn 260 0 increased to keep IRS1 const
R50r1 IRS degrade k_irs_basal_degr 10-3 1 Lifetime of ~2 days
R50r2 IRS-Yp degr k_irs_basal_degr 10-3 1 as R50r2
R50r3 IRS1-Sp degr k_irs_polyserp_degr 10-2 1 10 × faster than r50r2 [43]
R51 IRS-SerP by IKK_P kcat51 0.87 consistent with [43] and IKK/JNK
activation
IRS-SerP by IKK_P Km51 100 as above
R52 IRS-SerP by JNK_P kcat52 6.95 as R51
IRS-SerP by JNK_P Km52 100 as above
Phosphatases R30f oxidation of PTP1B k30f 0.08 2 [18,19]
m8b2_phosph.
6.mod
R30r reduction of PTP1B
by GSH
k30r 5 × 10-3 2 [18-20]
R31f oxidation of PTEN k31f 2.7 × 10-4 2 slower than R30f
R31r reduction of PTEN
by GSH
k31r 2 × 10-3 2 similar to R30r
R34f Activation of NOX k34f 2 × 10-5 2 consistent with R35
R34r1 NOX deactivation k34r1 10-3 2 consistent with R35
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Table 2 Parameter values of the model (except for FOXO part) (Continued)
R34r2 NOX inactivation(1) k34r2 0.25 1 consistent with R35
R34r3 NOX deact- > inact k34r3 10-3 2 consistent with R35
R35f ROS production by NOX k35f 450 1 fitted to get desired ROS level
(30/5) and PTP1B inhibition [18]
R35r ROS elimination by
SOD2
k35r 0.12 2 lifetime < 0.01 s
R36f ROS production by
Mitoch
k36f 180 1
R37f, R37r ROS transport across
plasma membrane
ros_perm 7.8 × 108
(thousands cm-2min-1)
1 [35]
membrane_area 6.5 × 10-9 cm2 from volume
k_ros_perm 4.8 thousands min-1 product of above
R38f Glutathione oxidation k38f 0.05 2 see R38f
R38r Glutathione reduction k38r 2 1 (auto-reduction)
Akt R14f PI(3,4,5)P3 generation,
basal
k9_basal 0.13145 1 [26]
m8b2_akt.6.mod By PI3K complex k9 0.055 2 (cat) derived from [26]
R14r PIP3 breakdown, basal kminus9_basal 2.7 1 [26]
by PTEN kminus9 0.0014 2 (cat)
R16f Akt activation k11 2.5 × 10-5 2 modified mass action, effect
similar to express in [26]
pip3_basal 200 2 (cat) offset
R16r Akt deactivation by
PP2A
kminus11 1.188 × 10-6 2 (cat) [26]
R17f PKC activation k12 3.5 × 10-5 2 (cat) as R16f
R17r PKC deactivation kminus12 1.25 × 10-6 2 (cat) as R16r
R16a AS160 activation by AKT kr16a 3.33 × 10-4 2 (cat) see methods; [26,36]
R16r AS160 deactivation kminusr16a 1 × 10-6 2 (cat) see R16a
R20f GLUT4 translocation to
cell surface; basal
k13_basal 0.015 1 see R16a
and by AS160 k13 7.5 × 10-6 2 (cat) see R16a
R20r GLUT4 translocation to
cytoplasm
kminus13 0.167 1 see R16a
JNK R32f DUSP oxidation k32f 6 × 10-4 2 (cat) consistent with [16,35,44]
m8b2_jnk.6.mod R32r DUSP reduction by GSH k32r 4 × 10-4 2 (cat) as R32f
R42f JNK activation by ROS k42fa 2.5 × 10-4 2 (cat) as R32f
R42r JNK deactivation by
DUSP
k42r 0.5 × 10-6 2 (cat) as R32f
R43f IKK activation by ROS k43f 0.5 × 10-4 2 (cat) as R32f
R43r IKK deactivation k43r 0.5 × 10-6 2 (cat) as R32f
a k42f expressed as α × k42f’ where α = 5 and k42f’ = 0.5 × 10-4.
(phosphatases, Akt, JNK, FOXO).
Kinetic parameters of the model, except for the FOXO components. Units of rate constants are min-1 for first order or (number)-1 min-1 for second order.
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cytes that this involves the activation of NOX in a way
independent of downstream components of IS that are
downstream of IRS [18] Accordingly we include NOX
activated directly by Insulin, the NOX passing sponta-
neously into a deactivated state from which it only
slowly returns to the inactive state (Additional file 2:Figure S1A). The NOX-generated ROS is about fivefold
above the background level of Mitochondrially-
generated ROS (qualitative data from Mahadev et al.
[19], (Additional file 2: Figure S1A)) and decays in about
10 min.
It is difficult to quantify the difference between the back-
ground and Ins-stimulated ROS production in Mahadev
Table 3 FOXO parameters for synthesis, degradation, transport and PTMs
Process 2o rate constant
(#min-1)
Enzyme Enz # 1o rate const
(min-1)
PTM modifying
rate
Rate MF Reference
Synthesis (NULL→ FOXO) 0.0055 E2F1 300 5.5 [45] Figure 1
Cytoplasm→ nuclear transport - - - 0.1/0.55 = 0.182 [3], [46]
Akt-Phos Pa 0.1 [46]
IKK-Phos Pd 0.5 [47] Figure 1
JNK-Phos Pe 10 [44]
Nuclear→ cytoplasm transport - - - 0.1 × 0.55 = 0.055 [3], [46]
Akt-Phos Pa 10 [46]
IKK-phos Pd 10 [47]
JNK-Phos Pe 0.1 [44]
Nuclear→DNAbound
transport
- - - 0.25 [48]
Akt-Phos Pa 0.5 [49] Figure 6B
DNAbound→
Nuclear transport
- - - 0.25 × 0.5 = 0.125 [48]
basal phosphorylation 5 × 10-5
basal dephosphorylation 1 × 10-6
akt_phos_factor 6
ikk phos_factor 3
jnk phos_factor 2
FOXO→ FOXO_Pa akt phos_factor × basal
phosphorylation
Akt (104) 0.5 [50] Figure 1C
FOXO_Pa→ FOXO basal dephosphorylation PP2A 5 × 105 0.5
FOXO→ FOXO_Pd ikk phos_factor × basal
phosphorylation
IKK (104) 0.5 [47]
FOXO_Pd→ FOXO basal dephosphorylation PP2A 5 × 105 0.5
FOXO→ FOXO_Pe jnk phos_factor × basal
phosphorylation
JNK (104) 0.5 [44]
FOXO_Pe→ FOXO basal dephosphorylation PP2A 5 × 105 0.5
FOXO→ FOXO_pUb 1 × 10-6 SCF/MDM2 103 10-3 [45] Figure 1;
also [51]
Akt (Pa) 3 [45] Figure 1
IKK (Pd) 22 [47] Figure 5F
Degradation
(FOXO_pUb→ NULL)
1 × 10-4 Proteasome 103 0.1 [45] Figure 1
Kinetic parameters of the FOXO module of the model. Where a second-order rate constant is given and the Enzyme is time-varying, the Enz # and first order rate
constant columns show typical values when the process is activated. The PTM modifying rate refers to the way modifiable species are implemented in this
system: if the PTM is present, then the basal rate for the process (in the 1o rate column) is multiplied by the entry in the Rate MF (Multiplicative Factor) column.
Table 4 Parameters for FOXO mediated transcription
Protein FOXO- simulated
transcription ktransl
Basal transcription
kbasalt
RNA export
kexp
RNA degradation
kmdeg
RNA translation
ktransl
Protein
degradation kpdeg
Ref
InR 0.24 5.0 0.22 5.622 2.46 4.4× 10-3 [52,53]
SOD2 0.95 15.0 0.22 5.622 1.23 1.9 × 10-3 [52] [44,54]
Parameters for transcription, transport, translation and degradation of the FOXO-regulated InR and SOD2 genes and proteins.
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Figure 3 Long term effects and effects of inter-subsystem interactions (A) Fasting; Insulin receptors are upregulated during a fast
(left panel). Insulin is applied for 15 minutes at the beginning and end of the two-day period (dosing bars at t = 0 and t = 2785 in left panel)
producing the effect on the Insulin dose–response curve at the end of the fasting period shown in the right panel; (B) Interaction of Insulin
Stimulation and Oxidative stress; Insulin activates glucose uptake strongly; oxidative stress activates it weakly, but reduces the effect of insulin.
Data adapted from experiments by Archuleta et al. [17] in rat skeletal muscle; (C) Low oxidative stress increase antioxidant defence, high oxidative
stress decreases it. Data adapted from experiments by Essers et al. [44] in human DLD1 human colon carcinoma cells. Both simulation and
experiment at t = 960 min (16 h) after exposure.
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about 5× the background level of Mt-generated ROS, and
that even the NOX-generated ROS is low enough that
JNK activation by insulin is very low, enough to maintain
Akt-control of FOXO localization under insulin stimula-
tion. The parameters k30f, k30r and k35f were varied to fit
the timecourse of Insulin-stimulated PTP deactivation in
3T3-L1 cells [19] and reactivation in human A431 carci-
noma cells [58]. K35f is essential for a good fit.
Inhibition of PTEN by ROS is much weaker but
occurs at high cytoplasmic ROS levels in 3T3 cells [20]
and human neuroblastoma cells [21].ROS transport into and out of the cell was based on
the work reported in Adimora et al. in Jurkat T cells
[35]. The differences in the effect of membrane perme-
ability, SOD2 concentration and basal ROS production
are shown in Additional file 2: Figure S1C-E. We remark
that the molecule numbers of the ROS species in the
model are scaled such that each represents 1000 real
molecules (the same is true of the cytoplasmic SOD2
and PIP2/3 species).
JNK and IKK are activated by ROS directly, and by
ROS deactivating the DUSP that reverses the SAPK acti-
vation [59], and deactivating the GSH that reactivates
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about one hour in response to external ROS in Fao cells
[16]. The effects of ROS on activation of JNK and IKK
were arranged to reproduce the data from DLD1 cells
(human colon carcinoma) in Essers et al. [44]; with the
attribution of the inhibition at high oxidative stress to
IKK- mediated degradation of FOXO (measured in 293T
and MCF-7 cells by Hu et al. [47]). IKK and JNK also
lead to degradation of IRS1 through serine phosphoryl-
ation (Additional file 2: Figure S1B). Michaelis-Menten
rate laws were used for these phosphorylation reactions.
FOXO
The FOXO model was extended based on previous
work, using the same approach of scripting to generate
the species and reactions required to describe the mul-
tiple FOXO species with all allowed combinations of
PTMs. Compared to the previous paper, acetylation and
modifications by AMPK were omitted, but modifications
by Akt observed in CCL39 fibroblasts [3], by JNK in
DL23 cells (related to DLD-1 human colon carcinoma)
[60] and by IKK in 293T human kidney and MCF-7
human breast cancer cells [47] were included, with Akt
modification altering translocation (measured in CV1
African green monkey kidney fibroblasts [46]), opposed
by JNK (measured in human endothelial cells [61] and
DLD1 cells [44]), and with the modifications by Akt and
IKK [47] modulating degradation (for Akt, measured in
HepG2 human liver carcinoma cells [45]). The model of
transcription and translation was based originally on one
of the effect of osmotic stress on yeast [52], but some
parameters are substantially different. With the mass-
action laws, the fold-change on upregulation is
dependent only on the number of DNA-bound FOXO
molecules and the FOXO-stimulated and basal tran-
scription rates, with the other parameters affecting the
final absolute protein and mRNA levels and the time-
scales. The timescale of protein regulation is several
hours while the timescale of mRNA up- or down-
regulation is taken as being much more rapid than this
(tens of minutes); given this, it has little effect on the
timescale of protein regulation. Transcriptional parame-
ters were tuned so that SOD2 and InR showed stable
cycles under physiological insulin variation (Additional
file 3: Figure S2).
Model simulations
The model reproduces previously calculated time cour-
ses of downstream activation in response to high insulin
[26] (Figure 2A) and the corresponding observed dose–
response curves to insulin, which were taken from
experiments on rat adipocytes [36](Figure 2B). We use
GLUT4 cell surface localization as a proxy for glucose
uptake throughout. It will be noted that it is foundexperimentally that insulin-stimulated glucose uptake
reaches saturation before either the Insulin receptors are
fully occupied or the downstream kinases are fully active
[36], though (at least in muscle) at this maximum only
about 60% of GLUT4 receptors are at the cell surface
[62]. It was found difficult to reproduce these observa-
tions with the original model architecture, where Akt
activation and GLUT4 translocation are described by
algebraic expressions depending on PIP3 levels; more-
over, it was felt preferable to use differential equations to
describe all reactions. By the introduction of an addi-
tional species, AS160, which mediates between Akt and
GLUT4 [55-57], it was possible to obtain the dose–re-
sponse curve in Figure 2B while still maintaining the
fractional activations both in the unstimulated and fully
stimulated states.
Signalling and feedback through IRS1
The insulin receptor substrate IRS1 is phosphorylated
on multiple serine as well as tyrosine residues, and the
serine phosphorylations tend to have the effect of redu-
cing downstream signalling, by reducing the rate of tyro-
sine phosphorylation and reducing the extent to which a
jointly Ser and Tyr phosphorylated IRS can signal to
PI3K [16,63] or interact with the insulin receptor InR
[64], though the details are complex and not fully eluci-
dated [65,66]. We have included a single “composite”
modification, IRS_PolySerP which may be present with
or without Tyr phosphorylation (so there are four IRS
species in the model, IRS1, IRS1_PolySerP, IRS1_TyrP
and IRS1_TyrP_PolySerP, the latter representing IRS
phosphorylated on both Ser and Tyr; this latter was not
included in the Sedaghat model, although the others
werer); IRS_PolySerP may be produced by SAPKs and
the activated form of PKC (representing the PKC-ζ iso-
form, activated by IS [67,68]). The rates of PKC modifi-
cation were set by fitting data of the timecourse of IRS
tyrosine phosphorylation from human adipocytes [27].
The Serine phosphorylation by PKC is a simple repre-
sentation in the model of the negative feedback loop that
stabilizes the basal response of insulin signalling [69].
The result is the model IRS tyrosine phosphorylation
timecourse of Figure 2C: initially it rises, within the first
minute of insulin stimulation; then as PKC becomes
active (after about 5 minutes) and produces serine phos-
phorylated forms of IRS, which do not signal down-
stream, IRS_TypP declines again.
Serine phosphorylation is also thought under many
circumstances to lead to accelerated degradation of IRS1
[43,70,71], though this may depend on the kinases
involved and on which and how many IRS1 sites are
modified. Therefore we have extended the Sedaghat
model by introducing synthesis and degradation reac-
tions for the various IRS species, and have taken the
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factor of 10, which is consistent with data for long-term
insulin stimulation in rat hepatoma (H4IIE) cells [43].
IRS is also serine phosphorylated by the SAPKs, JNK
and IKK in CHO and HEK 293 cells [63], 3T3-L1 cells
[71] and Fao rat hepatoma cells [16]; reviewed in [66].
We have selected the rates of phosphorylation by these
kinases so that IRS can be degraded on a timescale of
about 4–6 hours; the outcome is shown in Additional
file 2: Figure S1B.ROS interactions
ROS production, detoxification and signalling in the cell
is an extremely complex process and the model used here
(Figure 1D and E) is much simplified. Only a “generic”
ROS species representing superoxide or hydrogen pero-
xide is represented. Correspondingly, a single detoxifying
enzyme, called SOD2, is included, which removes this in
one step.
The direct interactions of oxidative stress with IS
occur via the phosphatases PTEN and PTP1B. The
insulin signal is transduced by tyrosine phosphorylation
(in the Insulin receptor and IRS) and lipid phosphory-
lation (of PIP2 to PIP3), processes which are reversed by
phosphatases (PTP1B and PTEN) that contain vital cys-
teine residues. These catalytic cysteines can be reversibly
oxidised by ROS, inactivating the enzyme. Indeed, they
are more susceptible to oxidation than the majority of
protein cysteines precisely because they are in a protein
environment that lowers their pKa in order to give them
their catalytic property. Accordingly, ROS is produced
by NOX enzymes in response to Insulin, facilitating the
activation of IS (Figure 1D). Detailed studies in 3T3-L1
adipocytes [18,19] have revealed the extent of ROS
production by NOX, and also that it deactivates after a
few minutes despite continuous Insulin stimulation. The
resultant ROS-mediated phosphatase inactivation is
shown in Figure 2D; it is apparent that more than half
the PTP is deactivated. PTEN behaves similarly but
more weakly; it is not appreciably deactivated by insulin-
stimulated ROS. Kinetics of NOX are shown in
Additional file 2: Figure S1A. The phosphatases are
reactivated on a timescale of 2–5 minutes in A431 cells
[58] (the rate depends on glutathione (GSH), which can
itself be oxidised by high ROS, although insulin signal-
ling alone does not appreciably reduce the availability of
glutathione). The effect of the PTP inhibition is to
increase the sensitivity of insulin signalling, moving the
GLUT4 dose–response curve to lower Insulin concen-
trations. This can be seen by setting NOX = 0 (equiva-
lent to inhibiting it, e.g. with DPI, or introducing a large
excess of antioxidants), which produces a decrease in
sensitivity (Figure 2E).ROS in the model is removed by cytoplasmic SOD2,
the activity of which ensures ROS decays on a timescale
of about 0.01 second. The ROS species can be exchanged
across the plasma membrane at a rate 7.4 × 108 m-2 s-1,
(derived from measurements on Jurkat T cells [35]), giving
a rate of 4.8/min with the chosen membrane area. The
existence of internal detoxification enzymes means that
ROS is removed as it diffuses into the cell. The back-
ground level of cytoplasmic ROS is taken to be 1 nM, and
with the above diffusion rate and SOD concentration, an
external concentration of 1000 times this can be tolerated
before the internal concentration begins to increase appre-
ciably (Figure 2F). The figure also shows that this thresh-
old depends on the SOD2 concentration.
The activation of the SAPK enzymes (JNK, IKK) in the
model depends directly on the concentration of cyto-
plasmic ROS, and by ROS deactivating the DUSP that
reverses the SAPK activation, and deactivating the GSH
that reactivates the DUSP (Figure 1E & D). The result is
a fairly abrupt activation of JNK and IKK, shown as a
function of external ROS concentration in Figure 2G.
The activation of IKK is chosen to begin at a higher level
of oxidative stress than JNK based on requirements of
FOXO response, as described below.
JNK activation modulates the activity of the FOXO
transcription factor, sending it to the nucleus and initia-
ting transcription (for FOXO4 this occurs by direct
phosphorylation [44]; similar JNK-dependent effects
seem to occur through other mechanisms for the other
FOXO factors, even though the phosphorylation sites
are not conserved [61,72]). Conversely, Akt, activated by
Insulin signalling, phosphorylates FOXO on different
sites and sends it to the cytoplasm [3,46], terminating
transcription. The cytoplasmic FOXO is also vulnerable to
degradation. Moreover, IKK can phosphorylate FOXO,
also deactivating it and accelerating its degradation [47].
In previous work [34] we produced a model of FOXO
including these (and other) effects, which is here linked to
the signalling pathways described above. The result is an
interplay between Insulin-driven deactivation and oxida-
tive stress driven activation, as shown in Figure 2H. The
fraction of DNA bound (transcriptionally active) FOXO
decreases at higher insulin, but it also increases once
external ROS passes the threshold at which internal ROS
begins to rise and JNK becomes active, only to fall again
once IKK is also activated, as IKK-phosphorylated FOXO
is expelled from the nucleus and degraded.
Pathway interactions and long-term processes
The above examples are all reasonably rapid processes.
We now turn to those on a rather longer timescale,
allowing for the interactions between the subsystems
and for processes of protein synthesis/degradation to
become more important. FOXO controls many genes,
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response kinases regulating FOXO allows the system to
respond to events that alter ROS through levels of
SOD2. Transcriptionally regulated species in the model
showed stable cycles during the physiological diurnal
variation of human insulin [73], as shown in Additional
file 3: Figure S2.
In Figure 3A we show the effect of long-term starva-
tion (Insulin withdrawal) on the InR level: over the
course of 48 hours it is upregulated roughly twofold.
The result of this is to increase the sensitivity to insulin;
as shown in the right-hand panel, the insulin dose–re-
sponse curve then moves appreciably to lower concen-
trations. The upregulation of the insulin receptor has
been shown qualitatively in C2C12 cells [74] and the
twofold upregulation is in agreement with experiments
in which FOXO is overexpressed in rat cardiomyocytes
[53]. For SOD2, regulated similarly, there is qualitative
data from MEFs and DL23 cells [60].
Figure 3B shows that the model is able to qualitatively
reproduce the experimentally-observed interaction bet-
ween Insulin signalling and Oxidative stress in rat skeletal
muscle [17,75,76]. Relative to basal activity, hydrogen
peroxide alone produces a weak activation of Glucose
uptake, Insulin produces a strong uptake, but the two
together, surprisingly, lead to an intermediate uptake.
Examination of the intermediate components of the
model show a possible explanation for this: with hydrogen
peroxide alone, signalling remains inactive in the model as
far as PI3K, but there is an increase in PIP3 above its basal
level because of partial oxidation of PTEN (~20%) redu-
cing its activity. This is sufficient to weakly activate Akt
and its downstream targets, producing some glucose up-
take. Conversely, with both Insulin and hydrogen peroxide
present, activation of the SAPKs causes serine phosphoryl-
ation of IRS1, sequestering it from Tyrosine phosphoryl-
ation and hence reducing the amount available to form
the IRS1-PI3K complex. The PTEN inactivation does not
compensate for this, hence the effect of Insulin and hydro-
gen peroxide is less than insulin alone. After 240 min,
there is appreciable IRS1 loss due to degradation of the
serine-phosphorylated form, which affects both the
Insulin-stimulated experiment and (to a greater extent)
the experiments where hydrogen peroxide is present. The
concentrations of hydrogen peroxide and Insulin used in
the simulation were Ins = 10 nM and extracellular ROS =
5 μM. The concentrations used in the experiment are not
known exactly, except that Insulin is saturating and the
oxidative stress (generated by glucose oxidase) was high.
Figure 3C shows dose–response bars indicating that
antioxidant defence (SOD2) can be upregulated by FOXO
at a low degree of oxidative stress, but at a high level it is
downregulated. There is reasonable agreement between
simulation and experiment [44], though the SOD2 fold-change is rather too small and the upregulation of FOXO
at low oxidative stress (caused by its nuclear location,
hence escaping some degradation) is not seen in this
experiment, though it was (under different experimental
conditions) in the data used to parameterize the earlier
FOXO model [45]. The simulation time at which these
results were observed was 960 min (16 h), and the Insulin
concentration was taken to be 2 nM.
We next investigated the longer term effects of oxida-
tive stress (Figure 4). Various initial oxidative stresses
were applied for one day (1440 minutes) followed by a
longer, higher basal oxidative stress lasting until 20 k
minutes (approximately 14 days). With no insulin pre-
sent (Figure 4A), preconditioning with various oxidative
stress (including zero, corresponding to the fasting situa-
tion) upregulates antioxidants, leading to a bifurcation
in the response: those that had low oxidative stress can
support a higher subsequent oxidative stress than those
that had a high initial stress, which downregulated anti-
oxidants. With higher 0.2 nM insulin (Figure 4B), this
bifurcation disappears; even though SOD2 may be ini-
tially downregulated to various extents, the subsequent
oxidative stress leads all the systems to converge to a
low SOD2 state. This contrasts somewhat with the result
on FOXO localisation in Figure 2H, which was mea-
sured at t = 60 min after application of the oxidative
stress. The high DNA-bound FOXO fraction at that time
slightly disguises a loss of FOXO due to IKK mediated
degradation.
Sensitivity analysis of the model has been carried out;
the results can be found as Additional files 4, 5 and 6.Discussion
By integrating and extending previous work, we have
produced an integrated model of insulin signalling and
oxidative stress and shown that it can reproduce mul-
tiple experimental observations of the response to these
stimuli in isolation and together.
With regard to the modelling approach adopted here, the
treatment of the multiple PTMs in the system, especially of
FOXO and IRS1, would be better treated in the rule-based
modelling/kappa calculus framework currently being inten-
sively developed [77-79] than by SBML. This would also
enable treatment of the many FOXO-interacting partners.
Nevertheless, we reproduced some of the flexibility of
rule-based modelling by using a scripting approach to gen-
erate reactions in SBML (see Methods). In addition, FOXO
mediated transcription would be better modelled within a
stochastic framework, which would allow the appreciable
degree of variability observed in the system on a cell-to-cell
basis to become apparent. However, our emphasis was on
using an integrative framework for all processes and there-
fore the established ODE approach was the best option.
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Figure 4 Effects of external oxidative stress “preconditioning” on later effect of higher oxidative stress. (A): Insulin = 0; effect of various
initial external ROS for 1440 min, followed by moderate external ROS of 20 μM for 20000 min, on Total FOXO, DNA bound FOXO, SOD2,
cytoplasmic ROS and total IRS; (B): as before, but with Insulin = 0.2 nM (# = 1000).
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http://www.biomedcentral.com/1752-0509/7/41Only a few key aspects of ROS production and detoxi-
fication have been treated in the current work. There are
several chemical species of importance, particularly
superoxide, produced by complexes I and III of the
electron transport chain; it is a highly reactive species that
is converted by superoxide dismutase (SOD) in mitochon-
dria and cytoplasm to hydrogen peroxide, which is itself
converted to water by catalases in mitochondria, cyto-
plasm and peroxisomes. In addition, superoxide and
hydrogen peroxide can be detoxified by reacting with SH
groups in GSH and Prx. Hydroxyl radicals can be pro-
duced by reaction of superoxide with Iron (II); they are
extremely reactive and will react with a nearby molecule
before they can be detoxified. Accordingly they are
handled by keeping Iron II and superoxide levels under
control and keeping iron sequestered in complexes [80]. A
detailed model of the antioxidant system featuring more
of these components awaits future work. In our current
model, only a “generic” ROS species representing super-
oxide or hydrogen peroxide is represented. Correspon-
dingly, a single detoxifying enzyme, SOD2, is included,
which removes this in one step, rather than the pair of an
SOD and catalase (not to mention the numerous enzymes
that use dithiol-disulphide conversions to remove ROS).
Recent modelling work has described interesting effects of
over/underexpression of particular enzymes in this detoxi-
fication pathway [81,82]. However the approach adopted
here can be justified at least in part by the fact that both
SOD2 and catalase seem to be regulated in parallel by
FOXO [54,83].
ROS can react with proteins, lipids and nucleic acids
to form a variety of adducts which are deleterious to a
greater or lesser extent. The process may or may not be
reversible. This general molecular damage is not expli-
citly represented in this work: more detailed models of
the effects of molecular damage and its resolution by
protein turnover [84-86] or the DNA damage response
[87,88] have been developed; in future work it would be
desirable to combine these and explicitly represent the
different damage inducing species superoxide, peroxide
and hydroxyl radical.
Although the production of ROS may appear to be a
process that is simply deleterious for an organism, the
situation is complicated by the intricacy of the antioxi-
dant system and the co-opting of ROS into signalling
pathways such as IS. This underlies the complicated
countervailing effects of ROS in the regulation of nutri-
ent uptake and related pathologies, such as diabetes
[22,55,89]; the present model is a first step to provide a
computational framework to address this. Moreover,
ROS signalling is important in the regulation of cell
growth and division in general: it is becoming clear that
changes in intracellular redox state coupled to ROS pro-
duction are important in the regulation of almost allphases of the cell cycle, including maintenance of a qui-
escent state and the G1/S transition [90]. FOXO, JNK
and PTP1B/PTEN all have important roles here, along
with many other proteins not treated in the current work
such as NRF2, p53, the CKIs, PP2A. SHP-2, LAR and
Cdc25. In yeast at least, the redox potential normally
cycles roughly in synchrony with the cell cycle [91]. More-
over, cellular senescence, apparently an anticancer adapta-
tion, proceeds through a feedback loop of ROS generation
[87]. Other essential processes in which ROS have a func-
tional role include inflammation and the killing of patho-
gens by the macrophage oxidative burst.
The activation of SAPKs occurs by similar mechanisms
to those outlined above for phosphatases: reversible
cysteine oxidation leads to release of upstream activating
enzymes from sequestering complexes and activates the
kinases after a phosphorylation cascade; cysteine oxidation
also leads to the blocking of their inactivating phospha-
tases (DUSPs) [59]. A more detailed model of the JNK
activation cascade was made by Ferrell and co-workers
[92], and it was found that in most cell types activation led
to an ultrasensitive activation kinetics. Activation of IKK
through TNFα was included in several models of NFκB
activation [93].
Although lack of correlation of antioxidant levels in
different organisms with lifespan, and the unexpected
effects of knockouts and dietary antioxidant supplemen-
tations have led some authors to suggest that the free
radical theory needs to be revised or rejected [14,15,94],
it remains plausible that the complexity and multifaceted
nature of the system could account for the observed
behaviour [95]. Exploration of this will require much fur-
ther development, but it has been begun in the recent
work on catalase/SOD [81], dithiol antioxidants and trans-
port of ROS [35] and antioxidant response through
KEAP/NRF2 [96,97], as well as that reported here, with
the introduction of the phosphatase inhibition, the inter-
action with SAPKs and the feedback regulation of FOXO.
The dose–response curve of FOXO-mediated anti-
oxidant regulation is at first puzzling. Upregulation of
antioxidant defences in the face of weak external oxida-
tive stress (through a JNK-mediated mechanism) is as
expected; however, high oxidative stress then leads to a
downregulation again (through an IKK mediated me-
chanism). Here we have concentrated only on describing
this effect; however evolutionarily it is hard to see what
its cause could be. It may simply be that the hydrogen
peroxide concentrations required to observe it (an extra-
cellular concentration of about 20 μM) are higher than
would ever be experienced by a cell in vivo, or it may be
that the mechanism is cell type specific. The IKK-
mediated mechanism could be activated in vivo by other,
more specific, activators of NFκB signalling such as
certain cytokines.
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based. Better constraints could be put on the model with
more detailed and more fully quantified timecourses
carried out in a single (or a few) cell types. Rather than
adhering to the minimal modelling approach [33,98], we
have not considered multiple model architectures, and
the architecture used is fairly complex, so we accept
that some parameters will not be uniquely determined.
Nevertheless, we have tried to avoid overfitting by exten-
sive human intervention in the fitting, to prevent sparse
data driving parameters to particularly large or small
values. The sensitivity analysis indicates that all parame-
ters have an effect on at least some species of the model
and so are likely to be at least in principle identifiable,
although due to the model architecture there may be
some unidentifiable parameter combinations; for exam-
ple the rate of FOXO synthesis is chosen to be, not a
zero-order process, but the product of an E2F1 trans-
cription factor species, whose number is assigned and
does not otherwise vary, and a per-molecule rate.
We have also found it necessary to use data sources
from multiple organisms and multiple tissues. Most of
them are adipocyte or adipocytes like (eg 3T3-L1 cells)
or skeletal muscle, the two most strongly insulin-
responsive tissues, from rodent (rat/mouse) or human
sources. Particularly in the FOXO part of the model,
however, other cell types have been used, such as human
colon and liver carcinoma (see text and Additional file 7).
Many mechanisms, particularly of core insulin signalling,
are strongly conserved among mammals and indeed bet-
ween mammals other vertebrates and even invertebrates,
but this feature of the model certainly emphasises the
need for independent experimental validation.
In this model we have begun to address transcriptional
feedbacks, but the simple nature of the treatment here be-
lies the extreme difficulty of handling this: antioxidants
are under the control of multiple transcription factors, but
the measurements of total protein or transcript level can
give no indication of which TF produced it. Hence we ex-
pect our long-time (FOXO-transcription-mediated) re-
sults will be qualitative only. The situation is further
complicated by the regulation of protein synthesis at the
translational level, the physical interaction of TFs with co-
factors or each other, and the transcription of one TF by
another [99]. For example FOXO exerts positive feedback
on its own synthesis [100], and there are additional mutual
regulations of FOXO, Akt and PP2A [101,102]. Achieving
biological realism here is a formidable task, but could lead
to a better understanding of the homeostatic and adaptive
behaviours of the pathway.
What, aside from chemical detail of the ROS, is miss-
ing in the model? Clearly the system as it stands is much
simplified. Other signalling pathways (p38 MAPK etc.)
and TFs (NFkB [103], NRF2 [96]) may also be activated byROS, and there are other effects, for example secretion of
inflammatory cytokines. This may lead to reinforcement
of inflammation by positive feedback generation of ROS, a
process which the current model could be extended to
describe. Moreover, a long exposure to anything more
than mild oxidative stress may induce apoptosis [104].
With regard to the nutrient sensing and response path-
ways, a full description would require the inclusion of the
mTOR (amino acid sensing) pathway along with AMPK
(total energy) and possibly sensing of other nutrients, such
as fatty acids, which give rise to inflammatory responses
and activate PKC. Modelling of fatty acid metabolism was
included in a model of glycolysis by Dash et al. [105].
Other work has already been done, which could be
combined with that reported here, including for example
insulin signalling combined with mTOR [29,106], AMPK
[107], and the ERK pathway [31]. Significantly, other
recent models of insulin signalling [33], as well as inclu-
ding mTOR signalling, have combined the cell signalling
model with a whole body model of insulin/glucose
dynamics [108].
Uptake of glucose and its transfer to mitochondria will
lead to an increase in the energy production of the cell,
but also the ROS output of the mitochondria. This has
been neglected in the current model for which mito-
chondrially generated ROS is a constant. This appro-
ximation is likely to be acceptable for a cell type such as
adipocytes, where the majority of ROS is signalling-
associated, but would certainly need to be revised in
order to extend the model to other cell types such as
muscle for which mitochondrially produced ROS consti-
tutes a larger fraction of the total. The energy demand
and the ratio of glucose to other fuel sources, (particularly
fatty acids, which may compete with carbohydrates [109]),
will also have an influence on mitochondrially-generated
ROS; see Fridlyand and Philipson for a review in the
context of diabetes [110]. This may be expected to occur
on a rather slower timescale than the signalling-related
ROS production included in the current model, but, (even
in adipocytes), will complicate the long-time effects which
lead to the activation of SAPKs and the induction of insu-
lin resistance. Hence, detailed modelling of mitochondria
may be required to fully understand the role of chronic
oxidative stress in the system. Mechanistic models of
glycolysis [111], oxidative phosphorylation [112] and ROS
production [113] in mitochondria have been produced
and will be combined with the current model in future
extensions.
Conclusion
We have adapted an existing model of insulin signalling,
integrated it with a model of FOXO regulation, and
expanded it by introducing regulations through oxidative
stress, to produce a model able to reproduce several
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to activate insulin signalling, endogenous ROS increase
the sensitivity of insulin signalling, and weak oxidative
stress or fasting upregulates antioxidants through a
homeostatic feedback mechanism, that increases the
level of oxidative shock that can be withstood for a
short time. Nevertheless long term high oxidative stress
leads to a collapse of the oxidative stress resistance
mechanism.
As outlined in the discussion, the current work
addresses only a part of this very complex system and
much more development, and extra experimental data,
will be required to make a truly biologically realistic
model of IS, FOXO and oxidative stress. Nevertheless
the current work makes it apparent how valuable such
an integrated model will be. A model including signal-
ling pathways from all three food groups, as outlined
above, combined with a whole body model of nutrient
flux, and the interactions with oxidative stress outlined
here, would be a powerful tool to address the progress
of insulin resistance to metabolic syndrome and T2D
[114], and how fuel use depends on overall nutrient
availability and energy expenditure [115]. FOXO is
known to contribute to the regulation of this [5], for
example by controlling the switching between gluco-
neogenesis and glycolysis through transcription of
PDK4, G6Pase and PEPCK; the model could be ex-
tended to include these genes downstream. It is appar-
ent that the modelling of nutrient signalling and
oxidative stress, to which the current work contributes,
is coming to a level of detail that enables it to address
interesting questions of life history, metabolic regula-
tion and disease.
Methods
Simulations were carried out with Copasi version 4.6
[116,117], using the particle number representation in
deterministic mode, and analysis was done with R ver-
sion 2.9.2 which was also used to produce the figures.
Particle numbers were converted to concentrations for
presentation. Fitting was done using Copasi’s Parameter
Estimation task, and parameter sensitivities calculated
with the Sensitivities tasks, using time series not steady
states. The model was developed using SBML shorthand
[118] in separate files corresponding to the modules of
Figure 1, which were converted into SBML prior to
importing into Copasi. Python scripts were used to
combine the individual module files and, in the case of
the FOXO module, to generate all species and reac-
tions corresponding to the different possible combina-
tions of PTMs and localization, as previously [34]. In
essence, this results in a simulation and analysis pipe-
line Python - > SBML-shorthand - > SBML - > Copasi - > R.
These scripts are available in supplementary material asAdditional files 8 and 9, and on GitHub (https://github.
com/graham1034/Smith2012_insulin_signalling), together
with the model files (SBML) of each module (Additional
file 10), and the complete model in two forms: initially
(with particle numbers as in Table 1), which was used to
produce the majority of the results (Additional file 11);
and after equilibration (taken from the end of the simu-
lation in Additional file 2: Figure S2, then further equil-
ibrated at constant low insulin of 0.2 nM for two more
days), which was used to produce the results in Figure 4
(Additional file 12). The first of these models. with
particle numbers at their initial levels, has been uploaded
to BIOMODELS (https://www.ebi.ac.uk/biomodels-main;
identifier MODEL1212210000). The differential equations
of the model are also available as Additional file 1.Additional files
Additional file 1: Differential equations of the model, exported
from Copasi and formatted with LaTeX.
Additional file 2: Description of Data: (A) Model kinetics of NOX
activation in response to 15 min insulin, and resulting ROS
production; (B) Degradation of IRS1 by prolonged high insulin
signalling (black) or high extracellular ROS (red); (C) Effect of
variation of basal intracellular ROS production (particle # Mt) on the
dependence of intracellular ROS on extracellular ROS; (D) Effect of
variation of intracellular antioxidants (particle # of SOD2) on the
dependence of intracellular ROS on extracellular ROS; (E) Effect of
variation of membrane permeability on the dependence of
intracellular ROS on extracellular ROS.
Additional file 3: Description of Data: Behaviour of key model
species through 5 days (7200 minutes) of human physiological
insulin variation. Insulin data taken from Frayn et al. [73].
Additional file 4: Description of Data: Sensitivity of model species
to parameter variation at 0.2 nM Insulin and zero external ROS.
Additional file 5: Description of Data: Sensitivity of model species to
parameter variation at 0.2 nM Insulin and 1 micromolar external ROS.
Additional file 6: Sensitivity Analysis.
Additional file 7: Table S5. Summary of experimental data sets used in
fitting the model; see text for additional references.
Additional file 8: Catshorthand python script. Description of Data:
Python script to concatenate sbml-shorthand model files, putting together
each section and removing species declarations that are repeated in
multiple models (the one in the first file on the command line will be kept).
Additional file 9: Make-foxo-shorthand python script. Description of
Data: Python script to make a SBML-shorthand (.mod) file for the FOXO
module by a rule-based approach, generating the species names and
equations interconverting them for all combinations of the PTMs of FOXO.
Additional file 10: Zip archive of model sbml-shorthand files.
Description of Data: zip archive containing SBML-shorthand files (.mod)
for receptor binding, akt, phosphatase, IRS, JNK and FOXO modules and
for events to set five days of physiological insulin variation as in Frayn
et al. m8b2_rapijf.mod is the result of assembling the files with $
catshorthand.py m8b2_recep.6.mod m8b2_akt.6.mod m8b2_phosph.6.
mod m8b2_irs.6.mod m8b2_jnk.6.mod m8b2_foxo.6.mod.
Additional file 11: SBML file of the complete model (initial state).
SBML file of the complete model with particle numbers as in Table 1.
Additional file 12: SBML file of the complete model (equilibrated).
SBML file of the complete model with equilibrated particle numbers after
physiol insulin cycles for 5 days then 2 more days equilibration at
constant Ins=1000 (0.2 nM).
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